DrugSupplement
Alpha-Linolenic Acid clinical trials
Also written ALA and ALA 10%.
- studies test it
- 17
- open now
- 3
- in phase 3
- 2
- first study started
- 2007
Keep track of what changes. Save the alpha-Linolenic Acid studies recruiting or about to start, and get an email each week — studies that open, close, add sites or post results.
Watch these studiesHow studies write it
Studies that test it under each name
Studies by the year they started
17 studies that test it; most in 2016 (2)
| Year | Studies |
|---|---|
| 2007 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 2 |
| 2018 | 2 |
| 2019 | 2 |
| 2021 | 2 |
| 2022 | 1 |
| 2024 | 1 |
| 2025 | 1 |
| 2026 | 2 |
By phase
A phase 1/2 study counts in both.
- Phase 1
- 3
- Phase 2
- 6
- Phase 3
- 2
- Phase 4
- 2
- No phase
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 4 · Other 13
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd. (2) · DUSA Pharmaceuticals, Inc. (2) · The University of Texas Health Science Center, Houston (1) · David W. Roberts (1) · Case Comprehensive Cancer Center (1) · Northwestern University (1) · Trabzon Kanuni Education and Research Hospital (1) · Merete Haedersdal (1)
Often tested with
Tested in the same studies.
Studies
Open first, then newest update. How each study uses alpha-Linolenic Acid is read from its arms, and is right about nine times in ten.
Testing it · 17
- Optimizing Integrative Oncology Approaches to Address Chemotherapy-induced Peripheral Neuropathy in Gastrointestinal (GI) Cancer Patients: A SMART Pilot StudyRecruitingNot applicableSidney Kimmel Comprehensive Cancer Center at Thomas Jefferson UniversityNCT07501663Written as α- Lipoic acid
- ALA-enriched Nutrition for Prevention of Cognitive Decline in APOE4 Older AdultsRecruitingPhase 2Michal Schnaider Beeri, Ph.D.NCT07392723Written as Alpha-Linolenic Acid (2.6 g/day)
- Aminolevulinic Acid-photodynamic Therapy for Facial Actinic Keratosis Treatment and PreventionRecruitingPhase 4Shanghai Dermatology HospitalNCT03642535Written as ALA
- Photodynamic Therapy For OnychomycosisActive, not recruitingPhase 1The University of Texas Health Science Center, HoustonNCT07756671Written as ALA 10% gel
- Diagnostic Performance of Fluorescein as an Intraoperative Brain Tumor BiomarkerActive, not recruitingPhase 2David W. RobertsNCT02691923Written as Fluorescein + ALA
- Photodynamic Therapy Incubation Times for Actinic KeratosisCompletedNot applicableNorthwestern UniversityNCT03066843Written as ALA (5-aminolevulinic acid)
- Alteration of the Immune Microenvironment in Basal Cell Carcinoma Following Photodynamic TherapyActive, not recruitingPhase 2Case Comprehensive Cancer CenterNCT05020912Written as ALA
- Investigation of the Protective Effect of Alpha Lipoic Acid on Ischemic Reperfusion Damage in Ischemic Priapism in RatsCompletedNot applicableTrabzon Kanuni Education and Research HospitalNCT07391709Written as Ischemic priapism + reperfusion + ALA
- The Effect of Alpha Linolenic Acid (ALA) Supplementation During PregnancyWithdrawnNot applicableSheba Medical CenterNCT03040856Written as Alpha Linolenic Acid
- Pharmacokinetics and Safety of ALA in Acne VulgarisCompletedPhase 1Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.NCT04044898Written as ALA 5%
- A Study on Safety and Preliminary Efficacy of ALA in Acne VulgarisCompletedPhase 1/2Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.NCT04018885Written as ALA 2.5%
- TMFI Enhances Skin Surface and Epidermal PpIX FluorescenceCompletedPhase 4Merete HaedersdalNCT04221126Written as ALA cream
- Fatty Acid Desaturase Gene Locus Interactions With Diet (FADSDIET2)CompletedNot applicableUniversity of Eastern FinlandNCT03572205Written as ALA
- Microneedle Lesion Preparation Prior to Aminolevulinic Acid Photodynamic Therapy (ALA-PDT) for AK on FaceCompletedPhase 2DUSA Pharmaceuticals, Inc.NCT02632110Written as ALA
- Phase 3 Study of Levulan With New Blue Light for AK on the Face or ScalpWithdrawnPhase 3DUSA Pharmaceuticals, Inc.NCT03024060Written as ALA
- Effects of α-linolenic Acid Supplementation on Hemostasis in Nondiabetic and Hypercholesterolemic SubjectsCompletedPhase 3Yonsei UniversityNCT02609295Written as ALA group
- Use of Flaxseed(Alpha Linolenic Acid) Powder in Morbidly Obese Patients With Systemic InflammationStatus unknownPhase 2University of Sao PauloNCT00502021Written as Alpha-linolenic acid/ALA
Given in every arm · 1 — alpha-Linolenic Acid is usual care beside what is tested
Codes
What other systems call alpha-Linolenic Acid · ClinicalTrials.gg INT008619
- MeSH (NLM) D017962alpha-Linolenic AcidConfirmed NLM, Wikidata
- UNII (FDA) 0RBV727H71LINOLENIC ACIDConfirmed FDA, NLM, Wikidata
- RxNorm 52071Confirmed FDA, Wikidata
- Wikidata Q256502alpha-linolenic acidConfirmed FDA, NLM, Wikidata
- NCI Thesaurus C997Linolenic AcidOne source FDA
- DrugBank DB00132One source Wikidata
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D017962 | alpha-Linolenic Acid | Confirmed NLM, Wikidata |
| UNII (FDA) | 0RBV727H71 | LINOLENIC ACID | Confirmed FDA, NLM, Wikidata |
| RxNorm | 52071 | — | Confirmed FDA, Wikidata |
| Wikidata | Q256502 | alpha-linolenic acid | Confirmed FDA, NLM, Wikidata |
| NCI Thesaurus | C997 | Linolenic Acid | One source FDA |
| DrugBank | DB00132 | — | One source Wikidata |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.